Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-06
DOI
10.3389/fmed.2021.686165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients
- (2021) Ilaria Durosini et al. Frontiers in Public Health
- A future for regulatory science in the European Union: the European Medicines Agency’s strategy
- (2020) Philip A. Hines et al. NATURE REVIEWS DRUG DISCOVERY
- Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
- (2020) Philip A. Hines et al. Frontiers in Medicine
- Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives
- (2020) Lylia Chachoua et al. Frontiers in Medicine
- From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk Tradeoffs
- (2019) Tommi Tervonen et al. MEDICAL DECISION MAKING
- Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US
- (2019) Chiara Whichello et al. Frontiers in Pharmacology
- Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review
- (2019) Rosanne Janssens et al. BMC Medical Informatics and Decision Making
- Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
- (2019) Sagar Lonial et al. LANCET ONCOLOGY
- Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
- (2019) Eline van Overbeeke et al. Frontiers in Pharmacology
- NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
- (2018) Shaji K. Kumar et al. Journal of the National Comprehensive Cancer Network
- CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment
- (2018) Clare Y. Slaney et al. Cancer Discovery
- Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review
- (2018) Eline van Overbeeke et al. DRUG DISCOVERY TODAY
- Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma
- (2017) Douwe Postmus et al. ONCOLOGIST
- MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment
- (2017) Tommi Tervonen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Multiple myeloma: practice patterns across Europe
- (2016) Marc S. Raab et al. BRITISH JOURNAL OF HAEMATOLOGY
- Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulators
- (2016) D Postmus et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Multiple myeloma epidemiology and survival: A unique malignancy
- (2016) Dickran Kazandjian SEMINARS IN ONCOLOGY
- How to use the nominal group and Delphi techniques
- (2016) Sara S. McMillan et al. International Journal of Clinical Pharmacy
- Multiple myeloma
- (2015) Christoph Röllig et al. LANCET
- Shared decision making: Concepts, evidence, and practice
- (2015) A.M. Stiggelbout et al. PATIENT EDUCATION AND COUNSELING
- Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA
- (2015) Axel C. Mühlbacher et al. Applied Health Economics and Health Policy
- Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
- (2013) Mickael Hiligsmann et al. Patient Preference and Adherence
- Decision Support for Patients
- (2012) Hilary A. Llewellyn-Thomas et al. MEDICAL CARE RESEARCH AND REVIEW
- Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations
- (2011) Joanna Coast et al. HEALTH ECONOMICS
- Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
- (2011) John F.P. Bridges et al. VALUE IN HEALTH
- Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research
- (2010) Cicely Kerr et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Qualitative research and content validity: developing best practices based on science and experience
- (2009) Meryl Brod et al. QUALITY OF LIFE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now